MRNA logo

Moderna (MRNA) Return On Equity

Annual ROE

-28.77%
-0.18%-0.63%

December 31, 2024


Summary


Performance

MRNA ROE Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherMRNAprofitabilitymetrics:

Quarterly ROE

-29.09%
-11.65%-66.80%

December 31, 2024


Summary


Performance

MRNA Quarterly ROE Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherMRNAprofitabilitymetrics:

ROE Formula

ROE =  Net Income
Shareholders Equity
✕ 100%

MRNA ROE Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-0.6%-1.5%
3 y3 years-119.7%-1.5%
5 y5 years+24.3%-1.5%

MRNA ROE Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-119.7%at low-117.8%+31.8%
5 y5-year-119.7%+28.1%-117.8%+31.8%
alltimeall time-102.3%+94.7%-102.5%+98.2%

Moderna ROE History

DateAnnualQuarterly
Dec 2024
-28.77%(+0.6%)
-29.09%(+66.8%)
Sep 2024
-
-17.44%(-59.1%)
Jun 2024
-
-42.65%(+8.5%)
Mar 2024
-
-39.30%(+37.1%)
Dec 2023
-28.59%(-156.9%)
-28.66%(+42.9%)
Sep 2023
-
-20.06%(-402.1%)
Jun 2023
-
6.64%(-74.7%)
Mar 2023
-
26.27%(-45.8%)
Dec 2022
50.27%(-65.6%)
48.44%(-36.3%)
Sep 2022
-
76.08%(-28.5%)
Jun 2022
-
106.42%(-24.6%)
Mar 2022
-
141.06%(-13.6%)
Dec 2021
146.08%(-465.3%)
163.25%(+20.2%)
Sep 2021
-
135.86%(+46.2%)
Jun 2021
-
92.90%(+327.1%)
Mar 2021
-
21.75%(-164.5%)
Dec 2020
-39.99%(+5.2%)
-33.70%(+10.3%)
Sep 2020
-
-30.55%(+4.7%)
Jun 2020
-
-29.18%(-20.9%)
Mar 2020
-
-36.88%(-3.3%)
Dec 2019
-38.00%(+6.4%)
-38.12%(-4.8%)
Sep 2019
-
-40.05%(-1.5%)
Jun 2019
-
-40.66%(+6.9%)
Mar 2019
-
-38.04%(+6.5%)
Dec 2018
-35.70%(+2.3%)
-35.71%(-91.7%)
Sep 2018
-
-429.65%(+36.9%)
Jun 2018
-
-313.88%(-30.7%)
Mar 2018
-
-452.65%(+62.9%)
Dec 2017
-34.89%(-27.4%)
-277.89%(+81.4%)
Sep 2017
-
-153.22%(+24.7%)
Jun 2017
-
-122.89%(+44.2%)
Mar 2017
-
-85.20%(+51.4%)
Dec 2016
-48.09%(-103.8%)
-
Dec 2016
-
-56.27%(-297.9%)
Sep 2016
-
28.44%(-90.3%)
Jun 2016
-
293.00%(-129.9%)
Mar 2016
-
-980.38%(+361.5%)
Dec 2015
1268.82%(+756.3%)
-212.45%(-32.4%)
Sep 2015
-
-314.37%(<-9900.0%)
Jun 2015
-
0.04%(-100.1%)
Mar 2015
-
-56.00%(-154.4%)
Dec 2014
148.18%(+566.3%)
102.88%(-49.7%)
Sep 2014
-
204.39%(+44.1%)
Jun 2014
-
141.86%(-30.1%)
Mar 2014
-
202.91%(+566.2%)
Dec 2013
22.24%(-86.9%)
30.46%(-60.1%)
Sep 2013
-
76.25%(-29.5%)
Jun 2013
-
108.10%(+13.5%)
Mar 2013
-
95.25%(-67.2%)
Dec 2012
169.62%(-149.6%)
290.02%(-120.9%)
Sep 2012
-
-1389.91%(+190.0%)
Jun 2012
-
-479.24%(+51.0%)
Mar 2012
-
-317.42%(+48.2%)
Dec 2011
-342.00%(-36.6%)
-214.21%(+50.9%)
Sep 2011
-
-141.91%(-56.7%)
Jun 2011
-
-327.55%(-79.5%)
Mar 2011
-
-1601.52%(-279.4%)
Dec 2010
-539.78%(-561.9%)
892.67%(+259.6%)
Sep 2010
-
248.26%(+5.2%)
Jun 2010
-
236.04%(-42.9%)
Mar 2010
-
413.63%(+33.2%)
Dec 2009
116.85%
310.60%(-73.3%)
Sep 2009
-
1161.81%(-292.2%)
DateAnnualQuarterly
Jun 2009
-
-604.48%(+66.4%)
Mar 2009
-
-363.28%(+2.9%)
Dec 2008
-329.36%(+159.6%)
-353.10%(+64.0%)
Sep 2008
-
-215.31%(+41.5%)
Jun 2008
-
-152.14%(+33.1%)
Mar 2008
-
-114.30%(+17.9%)
Dec 2007
-126.88%(+133.4%)
-96.96%(+7.3%)
Sep 2007
-
-90.34%(+23.9%)
Jun 2007
-
-72.94%(+35.3%)
Mar 2007
-
-53.91%(+6.2%)
Dec 2006
-54.35%(-3.9%)
-50.77%(+15.0%)
Sep 2006
-
-44.16%(-5.8%)
Jun 2006
-
-46.89%(-24.5%)
Mar 2006
-
-62.07%(+6.1%)
Dec 2005
-56.57%(-24.8%)
-58.48%(-8.2%)
Sep 2005
-
-63.70%(-16.8%)
Jun 2005
-
-76.56%(-16.5%)
Mar 2005
-
-91.70%(-27.6%)
Dec 2004
-75.23%(+366.4%)
-126.60%(-30.7%)
Sep 2004
-
-182.65%(+18.0%)
Jun 2004
-
-154.75%(+250.0%)
Mar 2004
-
-44.21%(+210.9%)
Dec 2003
-16.13%(-86.7%)
-14.22%(+0.1%)
Sep 2003
-
-14.20%(-321.5%)
Jun 2003
-
6.41%(-105.8%)
Mar 2003
-
-109.84%(+13.4%)
Dec 2002
-121.67%(+52.0%)
-96.88%(+27.7%)
Sep 2002
-
-75.89%(+11.5%)
Jun 2002
-
-68.08%(-13.5%)
Mar 2002
-
-78.72%(-7.4%)
Dec 2001
-80.07%(+8.1%)
-85.02%(+17.4%)
Sep 2001
-
-72.39%(-18.7%)
Jun 2001
-
-89.00%(+5.8%)
Mar 2001
-
-84.09%(+10.4%)
Dec 2000
-74.08%(+85.6%)
-76.14%(-0.2%)
Sep 2000
-
-76.27%(+41.5%)
Jun 2000
-
-53.91%(+24.8%)
Mar 2000
-
-43.21%(+11.2%)
Dec 1999
-39.91%(+1017.9%)
-38.86%(+35.6%)
Sep 1999
-
-28.66%(+42.5%)
Jun 1999
-
-20.11%(+51.1%)
Mar 1999
-
-13.31%(+243.9%)
Dec 1998
-3.57%(-85.4%)
-3.87%(-40.6%)
Sep 1998
-
-6.51%(-38.7%)
Jun 1998
-
-10.62%(-27.1%)
Mar 1998
-
-14.57%(-24.6%)
Dec 1997
-24.52%(+495.1%)
-19.33%(+53.3%)
Sep 1997
-
-12.61%(+126.8%)
Jun 1997
-
-5.56%(+173.9%)
Mar 1997
-
-2.03%(-221.6%)
Dec 1996
-4.12%(-412.1%)
-
Sep 1996
-
1.67%(>+9900.0%)
Jun 1996
1.32%(-178.6%)
0.00%(-100.0%)
Mar 1996
-
-3.94%(-49.7%)
Dec 1995
-
-7.84%(+103.1%)
Sep 1995
-
-3.86%(+101.0%)
Jun 1995
-1.68%(-136.1%)
-1.92%(-142.0%)
Mar 1995
-
4.57%(-1.1%)
Dec 1994
-
4.62%(-1.3%)
Sep 1994
-
4.68%(-52.4%)
Jun 1994
4.65%
9.84%(+29.6%)
Mar 1994
-
7.59%(-29.8%)
Dec 1993
-
10.81%(-127.0%)
Sep 1993
-
-40.00%

FAQ

  • What is Moderna annual return on equity?
  • What is the all time high annual ROE for Moderna?
  • What is Moderna annual ROE year-on-year change?
  • What is Moderna quarterly return on equity?
  • What is the all time high quarterly ROE for Moderna?
  • What is Moderna quarterly ROE year-on-year change?

What is Moderna annual return on equity?

The current annual ROE of MRNA is -28.77%

What is the all time high annual ROE for Moderna?

Moderna all-time high annual return on equity is 1268.82%

What is Moderna annual ROE year-on-year change?

Over the past year, MRNA annual return on equity has changed by -0.18% (-0.63%)

What is Moderna quarterly return on equity?

The current quarterly ROE of MRNA is -29.09%

What is the all time high quarterly ROE for Moderna?

Moderna all-time high quarterly return on equity is 1161.81%

What is Moderna quarterly ROE year-on-year change?

Over the past year, MRNA quarterly return on equity has changed by -0.43% (-1.50%)